Review Covid-19 (sars-cov-2) and medicinal plants ­ literature

Cassaro, Luís Antônio Gomes; Moretto, Lorena de Fátima; Batista, Aline Cristiane Cechinel Assing; Santos, Isabela Carvalho dos; Trevisani, Adriane Cordeiro; Belettini, Salviano Tramontin; Rey, Laisa Marina Rosa; Zardeto, Giuliana; Ceranto, Daniela de Cassia Faglioni Boleta; Mendonça, Juliana Aparecida; Cogo, Juliana; Alexandre, Monica Micheli; Gazim, Zilda Cristiani; Lourenço, Emerson Luiz Botelho; Barbosa, Lidiane Nunes; Gonçalves, Daniela Dib.
Arq. ciências saúde UNIPAR ; 26(3): 1376-1397, set-dez. 2022.
Artículo en Inglés | LILACS | ID: biblio-1414509

Documentos relacionados

  1. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
  2. Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: Review and Appraisal of Current Evidence.
  3. Anti-inflammatory and immune therapy in severe coronavirus disease 2019 (COVID-19) patients: An update.
  4. The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19.
  5. An overview of antiviral strategies for coronavirus 2 (SARS-CoV-2) infection with special reference to antimalarial drugs chloroquine and hydroxychloroquine.
  6. Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.
  7. Effect of Chloroquine and Hydroxychloroquine on Cytokine Release Syndrome in Patients with COVID-19.
  8. Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
  9. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
  10. Treatment of COVID 19-Repurposing drugs commonly used in dermatology.